Connect with us

Health

newsGP – AstraZeneca’s lower efficacy has been questioned, but what about other considerations? – RACGP

Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.

Published

on

post featured image

News
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
The spotlight is on AstraZenecas candidate, co-developed with the University of Oxford, as Australia moves closer to its mid-February vaccine rollout.
As the US, UK and Europe continue to record thousands of daily new cases of COVID-19, it has been said time again that Australia is in an enviable position.The vaccine roadmap is expected to begin with…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending